Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
United States and research
di Pietro Greco
Investments in scientific research and technological development (R&D) are increasing again in the United States of America. After the stagnation and the following recession in 2009 and 2010 - the black years of the financial and economic crisis - the United States regain their trust in scientific knowledge and technological innovation. According to a recent report by the National Science Foundation, in 2011 the US invested $428.2 billion in R&D: over 20 billion more than 2010, with a net 2.8% increase after inflation, higher than the GDP increase by 1.8%.